Eli Lilly and Amazon announce agreements at JPMorgan conference
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Biotechnology and pharmaceuticals
Eli Lilly LLY cuts 2024 revenue outlook for weight-loss drugs
The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, Thursday, Nov. 14, 2024.…
Eli Lilly CEO Hopes New Weight-Loss Pill Approved Next Year
David Ricks, CEO of Eli Lilly Scott Mlyn | CNBC Eli Lilly It expects its experimental weight-loss pill to be…
Moderna lowers its sales forecast for 2025 by $1 billion
The Moderna Inc. headquarters in Cambridge, Massachusetts, USA, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | fake images…
Walgreens (WBA) earnings in the first quarter of 2025
People walk up to a Walgreens pharmacy on March 9, 2023 in New York City. Leonardo Muñoz | Corbis News…
Eli Lilly's lead in the obesity race has increased. Its recent stock performance says otherwise.
Eli Lilly investors have received some very good news in recent months, with one notable exception regarding the stock's performance.…
Medicare May Cover Eli Lilly's Zepbound for Sleep Apnea: Health Department Agency
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
FDA approvals fall in 2024, Transcarent acquires Accolade
Signs are seen outside the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, on August 29, 2020. Andrew…
J&J says lung cancer drugs Rybrevant and Lazcluze prolong survival
Niels Wenstedt | fake images Johnson & Johnson on tuesday said his lung cancer regimen keeps people alive for at…
Innovative biotech stocks have a good chance of breaking out in 2025
The trends may be turning in favor of biotech stocks in 2025 after several years of poor performance, but it…